EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced plans to participate in several investor conferences ...

Drugmakers are investing more in U.S. manufacturing as President Donald Trump threatens tariffs, but facilities can take ...

Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug ...

Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist, previously approved as IMCIVREE ® by the FDA, the EMA, and UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for obesity due to ...

As China rises and other global cities aggressively court biotech talent, Massachusetts faces a "contracting moment" that has ...

A webcast of the H.C. Wainwright presentation will be available on September 9 at 12:00 PM EDT. The webcast will be available to watch live and a replay will be available for approximately 90-days ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...

The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District ...